Laboratory Question for the Week of July 15, 2019
What are the possible consequences for applicable labs that fail to report data under PAMA?
What are the possible consequences for applicable labs that fail to report data under PAMA?
What information is applicable in the private-payer claims data for (PAMA) reporting?
When do labs meet the definition of “applicable laboratory” under CLFS?
When are laboratories required to report private-payer data under PAMA?
What is the Centers for Medicare & Medicaid Service’s (CMS) current guidance for date of service (DOS) for molecular pathology test regarding an ADLT?
How does the Eliminating Kickbacks in Recovery Act (EKRA) define labs?
What penalties are included in the Eliminating Kickbacks in Recovery Act of (EKRA)?
What guidance does the Centers for Medicare & Medicaid Services provide for tests on live tissue date of service (DOS)?
How many new waived tests will be effective in July 2019?
Did any codes receive new status indicators (SI) in the April 2019 Outpatient Prospective Payment System (OPPS)?
I have heard that the FDA will begin to regulate lab-developed tests (LDTs). Can you provide any information about this?
What are the four new PLA codes released in April 2019?
CPT® copyright 2025 American Medical Association (AMA). All rights reserved.
Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
CPT is a registered trademark of the American Medical Association.
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 1 with code CYBER25
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24